Overview

Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy Subjects

Status:
Completed
Trial end date:
2008-10-12
Target enrollment:
Participant gender:
Summary
This study will examine safety of single doses of GSK369796 in healthy subjects, along with some test to examine how quickly GSK369796 gets in your blood, and how long it takes your body to get rid of it.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Collaborator:
Medicines for Malaria Venture
Treatments:
Antimalarials